McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulators

The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their pitch.

Related Keywords

Colorado ,United States ,New York ,Manhattan ,Massachusetts ,American ,Rob Rosiello ,Laura Moran ,Sarah Nam ,Tom Latkovic ,Carolyn Maloney ,Martin Elling ,Eli Lilly ,Jeff Smith ,Arnab Ghatak ,Alexm Azar ,Human Services ,Purdue Pharma ,Drug Administration ,New York Times ,Department Of Health ,Mckinsey Company ,House Committee On Oversight ,Azar Senate ,House Committee ,President Donald ,New York Democrat ,Midtown Manhattan ,Paul Mango ,Need Bolder Action ,Opioid Epidemic ,Mckinsey ,Conflict Of Interest ,Fda ,Opioids Opiates ,Regulation And Deregulation ,Pharmaceuticals Prescription Drugs ,Alex Azar ,